Avonex intramuscular injection 30 μg pen, from Biogen Japan, features Interferon beta-1a (genetically recombinant). This injectable drug (YJ code: 6399422G2023) is provided as 30μg in 0.5mL per kit and is used to treat relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Avonex intramuscular injection 30 μg pen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →